SPRY Stock Summary and Trading Ideas (Ars Pharmaceuticals | NASDAQ:SPRY)

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

What symbol and exchange does Ars Pharmaceuticals shares trade?

Ars Pharmaceuticals trades on the NASDAQ stock market under the symbol SPRY.

What is Ars Pharmaceuticals stock price doing today?

As of June 18, 2026, SPRY stock price declined to $9.65 with 1,801,407 million shares trading.

What is Ars Pharmaceuticals's Beta?

SPRY has a beta of 1.46, meaning it tends to be more sensitive to market movements. SPRY has a correlation of 0.08 to the broad based SPY ETF.

How much is Ars Pharmaceuticals worth?

SPRY has a market cap of $958.22 million. This is considered a Small Cap stock.

How much money does Ars Pharmaceuticals make?

Last quarter Ars Pharmaceuticals reported $23 million in Revenue and -$.61 earnings per share. This beat revenue expectation by $540,200 and missed earnings estimates by -$.08.

What is the highest and lowest price Ars Pharmaceuticals traded in the last 3 year period?

In the last 3 years, SPRY traded as high as $18.90 and as low as $2.55.

What are the top ETFs holding Ars Pharmaceuticals?

The top ETF exchange traded funds that SPRY belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWO.

Is Ars Pharmaceuticals (SPRY) a good investment?

SPRY has underperformed the market in the last year with a return of -39.3%, while SPY returned +26.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SPRY shares. However, SPRY has outperformed the market in the last 3 month and 2 week periods, returning +16.3% and +6.4%, while SPY returned +13.5% and -1.1%, respectively. This indicates SPRY has been having a stronger performance recently.

What are the support and resistance levels for Ars Pharmaceuticals (SPRY)?

SPRY support price is $9.46 and resistance is $10.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRY shares will trade within this expected range on the day.